karppaus.infon arkistoitu foorumi

Why wouldn’t doctors everywhere suggest carbohydrate restriction?

Vieläkään ei kansalle haluta kertoa, ettei pitäisi vetää hiilareita kaksin käsin, jos haluaa ehkäistä/korjata maksan ei-alkoholiperäisen rasvoittumisen.

Ilta-Sanomat: Noin miljoonalla suomalaisella on rasvamaksa – voi edetä osalla nopeasti vakavaksi sairaudeksi

From Dr Bret Scher at DietDoctor:
Fortunately, we have emerging evidence that low-carb and ketogenic diets improve fatty liver while also helping with glycemic control and weight loss, an impressive combination rarely seen with medications. As we reported earlier, studies have shown that carbohydrate restriction changes liver metabolism, stimulating the breakdown of liver fat. Another study mentioned in the same post showed that when children substitute sugar for more complex forms of starch, they experience reduced amounts of liver fat.
Yet another impressive study found that despite equal weight loss, a low-carb Mediterranean diet was better than a low-fat diet for reversing liver fat and signs of NAFLD. And finally, Virta Health published a subset of its data showing that one year on a ketogenic diet improved non-invasive tests for NAFLD and liver scarring.

Source: Limiting Carbs Likely Better Than Drugs for Fatty Liver — Diet Doctor

Conclusion: The CHO-restricted diet approach may be markedly beneficial in improving fatty liver, body composition, and insulin resistance in adolescents with NAFLD even in the absence of intentional caloric restriction. Practitioners should consider recommending this diet approach to effectively improve disease course in this patient population.

The presence of obesity in MAFLD patients was associated with a ~ 6-fold increased risk of severe COVID-19 illness (unadjusted-OR 5.77, 95% CI 1.19–27.91, p = .029).

Conclusions: A ketogenic, hypocaloric resulted in striking weight loss and significant improvements in metabolic parameters and liver tests, suggesting that this approach carries promise for the dietary management of patients with NASH.